they are thus established as first-line therapies for obesity and are being validated for wider indications
Ballester LY, Glitza Oliva IC, Douse DY, Chen MM, Lan C, Haydu LE, Huse JT, Roy-Chowdhuri S, Luthra R, Wistuba II, Davies MA
New drug delivery systems developed for brain targeting
Phosphoproteomic Analysis of Cell Signaling Events Induced by Treatment of Multiple Myeloma Cells
Why Researchers Choose Synagenics: Batch-specific COAs not generic reports Independent analytical verification 99% HPLC purity standards Research documentation with every batch Laboratory research support resources available Researchers may also review metabolic research literature and peptide studies available through the Synagenics Blog Hub